Cain McClary
InvestorManaging Partner at KdT Ventures
Austin, Texas
Writes $500K β $3M checks Β· typically $850K
About
Physician-scientist turned venture capitalist who trained and practiced pathology at Stanford, bringing diagnostic and clinical expertise plus a multi-dimensional, creative (Dad, DJ, Doctor, Outdoor Enthusiast, Type-A) viewpoint to medical startups.
Invests in
AgTechAI & Machine LearningBiotechFoodTechHealthtechNew Materials
Experience
- KdT VenturesFounder and Managing Partnercurrent2017 β present
- InvestorTrying to Helpcurrent2010 β presentAsheville, NC
- 8VCAdvisorcurrent2017 β presentSan Francisco, California
- Tulane University School of MedicineClinical Instructor and Visiting Professorcurrent2017 β presentGreater New Orleans Area
- Included HealthStaff Physician and Analytics/Data Science Lead2014 β 2017San Francisco Bay Area
- Stanford UniversityConsulting Assistant Professor2015 β 2017
- Stanford University Medical CenterPathologist2012 β 2015Palo Alto, CA
- Howard Hughes Medical InstituteResearch Scholar2010 β 2011Bethesda, MD
Education
- Brown UniversitySc.B., Biochemistry and Molecular Biology2003 β 2007
- Tulane University School of MedicineDoctor of Medicine (MD)2007 β 2012
- Stanford University School of MedicineResidency, Pathology2012 β 2015
- Baylor School1999 β 2003
Skills & more
+12 more
ResearchBiotechnologyDNABiochemistryImmunologyCancerBioinformaticsImmunohistochemistryGenomicsHealthcare improvementLife SciencesHealthcareFrom Cain's professional profile.
Same school
Also attended Brown University301
+ 295 more
Also attended Tulane University School of Medicine2
Also attended Stanford University School of Medicine67
+ 61 more
Shared employers
Also worked at Included Health3
Also worked at Stanford University401
+ 395 more
Also worked at Stanford University Medical Center25
+ 19 more
Also worked at Howard Hughes Medical Institute15
+ 9 more
Deals Β· 4
Elegen Corp.Board seat
via KdT Ventures Β· filed May 2024 Β· $36M raise
AzitraBoard seat
via KdT Ventures Β· filed Sep 2020 Β· $17M raise
Debut BiotechnologyBoard seat
via KdT Ventures Β· filed Jan 2020 Β· $2.6M raise
CheckerspotBoard seat
via KdT Ventures Β· filed May 2018 Β· $6.5M raise
Attribution from SEC filings, press coverage, and firm rosters.
Colleagues at KdT Ventures
Network5
Investors connected to Cain in public investor directories β a warm-intro map.

.png)

















.jpeg)



















